166 related articles for article (PubMed ID: 9516012)
1. Is maternal serum triple screening a better predictor of Down syndrome in female than in male fetuses?
Ghidini A; Spong CY; Grier RE; Walker CN; Pezzullo JC
Prenat Diagn; 1998 Feb; 18(2):123-6. PubMed ID: 9516012
[TBL] [Abstract][Full Text] [Related]
2. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
[TBL] [Abstract][Full Text] [Related]
3. Risk of abnormal triple screen for Down syndrome is significantly higher in patients with female fetuses.
Spong CY; Ghidini A; Stanley-Christian H; Meck JM; Seydel FD; Pezzullo JC
Prenat Diagn; 1999 Apr; 19(4):337-9. PubMed ID: 10327139
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
6. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
7. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
Sullivan A; Giudice T; Vavelidis F; Thiagarajah S
Am J Obstet Gynecol; 1999 Aug; 181(2):260-5. PubMed ID: 10454666
[TBL] [Abstract][Full Text] [Related]
8. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum screening for aneuploid pregnancy by alpha-fetoprotein, hCG, and unconjugated estriol.
Heyl PS; Miller W; Canick JA
Obstet Gynecol; 1990 Dec; 76(6):1025-31. PubMed ID: 1700348
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
11. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study.
Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701
[TBL] [Abstract][Full Text] [Related]
13. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
14. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
[TBL] [Abstract][Full Text] [Related]
15. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT
Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506
[TBL] [Abstract][Full Text] [Related]
18. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Bahado-Singh RO; Goldstein I; Uerpairojkit B; Copel JA; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1995 Oct; 173(4):1106-10. PubMed ID: 7485301
[TBL] [Abstract][Full Text] [Related]
19. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21.
Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA
Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888
[TBL] [Abstract][Full Text] [Related]
20. Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Palomaki GE; Haddow JE; Knight GJ; Wald NJ; Kennard A; Canick JA; Saller DN; Blitzer MG; Dickerman LH; Fisher R
Prenat Diagn; 1995 Aug; 15(8):713-23. PubMed ID: 7479589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
